Charles Bailey, MD, PhD, Co-Investigator; Economic Impact of Clinical Trials for Childhood Cancers

Charles Bailey, MD, PhD, is Co-Investigator on the UPenn PRC Economic Impact of Clinical Trials on Childhood Cancers Project. Dr. Bailey is a member of the Divisions of Oncology and Hematology at The Children’s Hospital of Philadelphia (CHOP). His clinical focus is on leukemia and lymphoma, and particularly on acute lymphoblastic leukemia, the most common type of childhood cancer. He also works on improving quality of supportive care for children with cancer.

Dr. Bailey’s research centers on the development of learning health systems which includes creating ways to share data across hospitals, to recognize the clinical implications of information gathered from different sources, and to provide support to clinicians in using this information more effectively. In order to help realize this, Dr. Bailey is involved in the building of the Epicare electronic health record for acute care at CHOP, and particularly in its implementation for Oncology patients, including the Beacon chemotherapy management module.

Dr. Bailey sits on CHOP's Clinical Decision Support committee, and the Division of Oncology's chemotherapy safety and quality improvement committees. He is an Assistant Professor of Clinical Pediatrics in the Perelman School of Medicine at the University of Pennsylvania.

To learn more, visit http://www.chop.edu/doctors/bailey-l-c#.VmXBuL9jx41